New Releases from NCBI BookshelfSacituzumab Govitecan (Trodelvy): CADTH Reimbursement Review: Therapeutic area: HR-positive, HER2-negative advanced or metastatic breast cancer [Internet].Sacituzumab Govitecan (Trodelvy): CADTH Reimbursement Review: Therapeutic area: HR-positive, HER2-negative advanced or metastatic breast cancer [Internet].

By / June 24, 2024

Post Content

New Releases from NCBI BookshelfTesting Whether a Referral to a Telehealth Program Helps African-American and Hispanic Adults with COPD Transition from Hospital to Home [Internet].Testing Whether a Referral to a Telehealth Program Helps African-American and Hispanic Adults with COPD Transition from Hospital to Home [Internet].

New Releases from NCBI BookshelfRavulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti–aquaporin 4 (AQP4) antibody–positive neuromyelitis optica spectrum disorder (NMOSD) [Internet].Ravulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti–aquaporin 4 (AQP4) antibody–positive neuromyelitis optica spectrum disorder (NMOSD) [Internet].

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top

Leave a Comment Cancel Reply

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.